178 related articles for article (PubMed ID: 2862574)
1. Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin.
Yamada S; Isogai M; Kagawa Y; Takayanagi N; Hayashi E; Tsuji K; Kosuge T
Mol Pharmacol; 1985 Aug; 28(2):120-7. PubMed ID: 2862574
[TBL] [Abstract][Full Text] [Related]
2. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
3. Neosurugatoxin, a specific antagonist of nicotinic acetylcholine receptors.
Hayashi E; Isogai M; Kagawa Y; Takayanagi N; Yamada S
J Neurochem; 1984 May; 42(5):1491-4. PubMed ID: 6707649
[TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular injection of neosurugatoxin induces a prolonged blockade of brain nicotinic acetylcholine receptors.
Yamada S; Ushijima H; Nakayama K; Hayashi E; Tsuji K; Kosuge T
Eur J Pharmacol; 1988 Nov; 156(2):279-82. PubMed ID: 3240770
[TBL] [Abstract][Full Text] [Related]
5. The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes.
Lippiello PM; Fernandes KG
Mol Pharmacol; 1986 May; 29(5):448-54. PubMed ID: 3702863
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antinicotinic activity by neosurugatoxin and the structurally related compounds.
Yamada S; Kagawa Y; Takayanagi N; Nakayama K; Tsuji K; Kosuge T; Hayashi E; Okada K; Inoue S
J Pharmacol Exp Ther; 1987 Dec; 243(3):1153-8. PubMed ID: 2891836
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and mechanism of L-[3H]nicotine binding to putative high affinity receptor sites in rat brain.
Lippiello PM; Sears SB; Fernandes KG
Mol Pharmacol; 1987 Apr; 31(4):392-400. PubMed ID: 3574288
[TBL] [Abstract][Full Text] [Related]
8. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
Weiland GA; Durkin JA; Henley JM; Simasko SM
Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
[TBL] [Abstract][Full Text] [Related]
9. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.
Costa LG; Murphy SD
J Pharmacol Exp Ther; 1983 Aug; 226(2):392-7. PubMed ID: 6875853
[TBL] [Abstract][Full Text] [Related]
10. Interactions of noncompetitive inhibitors with nicotinic receptors in the rat brain.
Takayama H; Majewska MD; London ED
J Pharmacol Exp Ther; 1989 Dec; 251(3):1083-9. PubMed ID: 2600805
[TBL] [Abstract][Full Text] [Related]
11. Melatonin modulation of presynaptic nicotinic acetylcholine receptors in the rat vas deferens.
Markus RP; Zago WM; Carneiro RC
J Pharmacol Exp Ther; 1996 Oct; 279(1):18-22. PubMed ID: 8858970
[TBL] [Abstract][Full Text] [Related]
12. Identification of putative high affinity nicotinic receptors on cultured cortical neurons.
Lippiello PM; Fernandes KG
J Pharmacol Exp Ther; 1988 Jul; 246(1):409-16. PubMed ID: 3292757
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
14. [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.
Martino-Barrows AM; Kellar KJ
Mol Pharmacol; 1987 Feb; 31(2):169-74. PubMed ID: 3807893
[TBL] [Abstract][Full Text] [Related]
15. Neosurugatoxin: CNS acetylcholine receptors and luteinizing hormone secretion in ovariectomized rats.
Billiar RB; Kalash J; Romita V; Tsuji K; Kosuge T
Brain Res Bull; 1988 Mar; 20(3):315-22. PubMed ID: 3365562
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain.
Bencherif M; Fowler K; Lukas RJ; Lippiello PM
J Pharmacol Exp Ther; 1995 Nov; 275(2):987-94. PubMed ID: 7473192
[TBL] [Abstract][Full Text] [Related]
17. Binding differences between nicotine and alpha-bungarotoxin in the rat brain.
Nukina I; Ogawa N; Takayama H; Ota Z
Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):141-4. PubMed ID: 2858912
[TBL] [Abstract][Full Text] [Related]
18. [3H]acetylcholine binding sites in brain. Effect of disulfide bond modification.
Schwartz RD; Kellar KJ
Mol Pharmacol; 1983 Nov; 24(3):387-91. PubMed ID: 6633505
[TBL] [Abstract][Full Text] [Related]
19. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
20. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
